ADMA Biologics, Inc. is a biopharmaceutical company focused on the development, manufacturing and commercialization of specialty plasma-derived biologics for the treatment and prevention of immune deficiencies and infectious diseases. Through its wholly owned plasma collection and manufacturing facilities, the company produces human immunoglobulin therapies designed to provide critical antibody support to patients with primary immunodeficiency disease and those at heightened risk for certain viral and bacterial infections.
The company’s principal commercial products include BIVIGAM, a 10% intravenous immunoglobulin (IVIG) therapy indicated for primary humoral immunodeficiency, and ASCENIV, a 10% IVIG hyperimmune globulin with elevated titers of antibodies against respiratory syncytial virus (RSV) and other respiratory pathogens. Both therapies are marketed in the United States and distributed through specialty pharmacies and hospitals. ADMA Biologics also maintains a proprietary plasma collection network that supplies raw material for its clinical and commercial programs.
Founded in 2006 and headquartered in Ramsey, New Jersey, ADMA Biologics expanded its operational footprint with a state-of-the-art plasma fractionation facility in Boca Raton, Florida. This facility supports scalable manufacturing capacity and enables the company to pursue additional late-stage clinical programs, including novel hyperimmune globulins targeting emerging viral infections. Over the years, ADMA has secured regulatory approvals, built strategic alliances for plasma sourcing, and strengthened its balance sheet through public offerings and private placements.
Under the guidance of a management team with extensive expertise in plasma biomanufacturing, regulatory affairs and commercial operations, ADMA Biologics continues to broaden its product portfolio and geographic reach. The company is committed to enhancing patient access to life-saving immunoglobulin therapies and advancing its pipeline to address unmet medical needs in immunology and infectious disease worldwide.
AI Generated. May Contain Errors.
Free ADMA Stock Alerts